Status
Conditions
About
Jangzhuo Qinggan prescription and irbesartan in the treatment of essential hypertension(Hepatogastric Damp-heat), randomized, parallel-controlled, multi-center clinical study.
Full description
Charged by the five research centers in line with traditional Chinese medicine hepatogastric Damp-heat syndrome 240 cases have hypertension, and overweight, as well as blood lipid disorders or diabetes were randomly divided into Chinese herbal compound Jiangzhuo Qinggan prescription group and western medicine irbesartan group.The treatment groups were compared 4-week step-down and regulation of blood lipids, blood sugar effect.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
240 participants in 2 patient groups
Loading...
Central trial contact
Fenglian Li, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal